205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.20%
Revenue growth under 50% of MU's 35.05%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-6.44%
Negative gross profit growth while MU is at 35.77%. Joel Greenblatt would examine cost competitiveness or demand decline.
-6.41%
Negative EBIT growth while MU is at 39.91%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-6.41%
Negative operating income growth while MU is at 39.91%. Joel Greenblatt would press for urgent turnaround measures.
0.69%
Net income growth under 50% of MU's 27.66%. Michael Burry would suspect the firm is falling well behind a key competitor.
-5.26%
Negative EPS growth while MU is at 27.45%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.26%
Negative diluted EPS growth while MU is at 27.45%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.57%
Share count expansion well above MU's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.27%
Reduced diluted shares while MU is at 0.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
2.54%
Dividend growth of 2.54% while MU is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
4.31%
OCF growth under 50% of MU's 22.64%. Michael Burry might suspect questionable revenue recognition or rising costs.
-94.07%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
137.93%
10Y revenue/share CAGR under 50% of MU's 7260.64%. Michael Burry would suspect a lasting competitive disadvantage.
76.91%
5Y revenue/share CAGR under 50% of MU's 733.69%. Michael Burry would suspect a significant competitive gap or product weakness.
71.38%
3Y revenue/share CAGR under 50% of MU's 572.45%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-9.01%
Negative 5Y OCF/share CAGR while MU is at 732.50%. Joel Greenblatt would question the firm’s operational model or cost structure.
42.84%
3Y OCF/share CAGR under 50% of MU's 772.00%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
665.18%
10Y net income/share CAGR of 665.18% while MU is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
548.82%
Below 50% of MU's 7901.67%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
257.19%
Below 50% of MU's 8472.42%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
128.96%
Below 50% of MU's 813.98%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
49.99%
Below 50% of MU's 234.43%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
98.79%
Below 50% of MU's 228.05%. Michael Burry suspects a serious short-term disadvantage in building book value.
4.56%
Dividend/share CAGR of 4.56% while MU is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
23.92%
Dividend/share CAGR of 23.92% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
29.96%
3Y dividend/share CAGR of 29.96% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.71%
Firm’s AR is declining while MU shows 32.96%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.77%
Inventory growth well above MU's 3.80%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.61%
Asset growth well under 50% of MU's 15.43%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
5.79%
Under 50% of MU's 16.84%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.21%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Our R&D shrinks while MU invests at 16.96%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
40.00%
SG&A growth well above MU's 23.35%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.